RMD » Topics » Signatures

This excerpt taken from the RMD 8-K filed Dec 23, 2009.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

    RESMED INC.
Date: December 23, 2009     By:   /s/    DAVID PENDARVIS        
    Name:   David Pendarvis
    Its:   Secretary, Global General Counsel and
      Senior Vice President – Organizational Development

 

4

This excerpt taken from the RMD 8-K filed Nov 23, 2009.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

    RESMED INC.
Date: November 23, 2009   By:  

/s/    David Pendarvis        

  Name:   David Pendarvis
  Its:  

Secretary, Global General Counsel and

Senior Vice President – Organizational Development

This excerpt taken from the RMD 8-K filed Nov 5, 2009.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: November 5, 2009     RESMED INC.
    (registrant)
    By:   /s/    BRETT SANDERCOCK        
    Name:   Brett Sandercock
    Its:   Chief Financial Officer

 

3


This excerpt taken from the RMD 8-K filed Oct 1, 2009.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: October 1, 2009   RESMED INC.
  By:  

/S/ DAVID PENDARVIS

  Name:   David Pendarvis
  Its:   Secretary, Global General Counsel and Senior Vice President – Organizational Development


This excerpt taken from the RMD 8-K filed Aug 6, 2009.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: August 6, 2009   RESMED INC.
  (registrant)
  By:  

/s/    Brett Sandercock

  Name:   Brett Sandercock
  Its:   Vice President Finance and Chief Financial Officer

 

3


This excerpt taken from the RMD 8-K filed Jun 24, 2009.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: June 19, 2009     RESMED INC.
      By:  

/s/    David Pendarvis

      Name:   David Pendarvis
      Its:  

Secretary, Global General Counsel and

Senior Vice President – Organizational Development


This excerpt taken from the RMD 8-K filed Jun 4, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 4, 2009     RESMED INC.
      By:   /s/ David Pendarvis
      Name:   David Pendarvis
      Title:  

Secretary, Global General Counsel and Senior Vice

President – Organizational Development

This excerpt taken from the RMD 10-Q filed May 8, 2009.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

May 7, 2009

 

ResMed Inc.

/s/ KIERAN T. GALLAHUE

Kieran T. Gallahue

Chief Executive Officer

(Principal Executive Officer)

/s/ BRETT A. SANDERCOCK

Brett A. Sandercock

Chief Financial Officer

(Principal Financial Officer)

 

- 46 -

This excerpt taken from the RMD 8-K filed May 7, 2009.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: May 7, 2009     RESMED INC.
    (registrant)
      By:   /s/ Brett Sandercock
      Name: Brett Sandercock
      Its: Vice President Finance and Chief Financial Officer

 

3


This excerpt taken from the RMD 8-K filed Mar 5, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 5, 2009     RESMED INC.
    By:   /s/ David Pendarvis
    Name:   David Pendarvis
    Its:   Secretary, Global General Counsel and Senior Vice President –Organizational Development


This excerpt taken from the RMD 10-Q filed Feb 6, 2009.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

February 6, 2009

 

ResMed Inc.

/s/ KIERAN T. GALLAHUE

Kieran T. Gallahue

Chief Executive Officer

/s/ BRETT A. SANDERCOCK

Brett A. Sandercock

Chief Financial Officer

 

- 48 -

This excerpt taken from the RMD 8-K filed Feb 5, 2009.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: February 5, 2009    

RESMED INC.

(registrant)

    By:   /s/ Brett Sandercock
    Name:   Brett Sandercock
    Its:   Vice President Finance and Chief Financial Officer

 

3


This excerpt taken from the RMD 8-K filed Dec 15, 2008.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: December 12, 2008     RESMED INC.
    By:   /s/ David Pendarvis
      Name:   David Pendarvis
      Its:   Secretary, Global General Counsel and Senior Vice President – Organizational Development
This excerpt taken from the RMD 8-K filed Nov 26, 2008.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

    RESMED INC.
Date: November 26, 2008     By:   /s/ David Pendarvis
        David Pendarvis
        Secretary, Global General Counsel and Senior Vice President – Organizational Development
This excerpt taken from the RMD 10-Q filed Nov 7, 2008.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

November 6, 2008

 

ResMed Inc.

/s/ KIERAN T. GALLAHUE

Kieran T. Gallahue

Chief Executive Officer

/s/ BRETT A. SANDERCOCK

Brett A. Sandercock

Chief Financial Officer

 

- 44 -

This excerpt taken from the RMD 8-K filed Nov 6, 2008.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: November 6, 2008    

RESMED INC.

(registrant)

    By:   /s/ Brett Sandercock
      Name:   Brett Sandercock
      Its:  

Vice President Finance and Chief Financial

Officer

 

3


This excerpt taken from the RMD 8-K filed Oct 6, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: October 6, 2008   RESMED INC.
  By:  

/s/ David Pendarvis

  Name:   David Pendarvis
  Its:   Secretary, Global General Counsel and Senior Vice President –Organizational Development


This excerpt taken from the RMD 8-K filed Aug 5, 2008.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: August 5, 2008    

RESMED INC.

(registrant)

    By:   /s/ Brett Sandercock
    Name:   Brett Sandercock
    Its:   Vice President Finance and Chief Financial Officer

 

3


This excerpt taken from the RMD 8-K filed Jun 5, 2008.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: June 5, 2008     RESMED INC.
      By:   /s/ David Pendarvis
      Name:   David Pendarvis
      Its:   Secretary, Global General Counsel and
Senior Vice President – Organizational Development
This excerpt taken from the RMD 10-Q filed May 8, 2008.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

May 7, 2008

ResMed Inc.

 

 

 

/s/ KIERAN T. GALLAHUE

 

Kieran T. Gallahue

Chief Executive Officer

 

 

 

 

/s/ BRETT A. SANDERCOCK

 

Brett A. Sandercock

Chief Financial Officer

This excerpt taken from the RMD 8-K filed May 1, 2008.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: May 1, 2008    

RESMED INC.

(registrant)

      By:   /s/ Brett Sandercock
      Name:   Brett Sandercock
      Its:   Vice President Finance and Chief Financial Officer

 

 

 

 

 

 

3


This excerpt taken from the RMD 8-K filed Apr 10, 2008.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: April 10, 2008     RESMED INC.
      By:   /s/ David Pendarvis
      Name:   David Pendarvis
      Its:  

Secretary, Global General

Counsel and Senior Vice

President – Organizational

Development

This excerpt taken from the RMD 8-K filed Mar 27, 2008.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: March 27, 2008   RESMED INC.
  By:  

/s/ David Pendarvis

  Name:   David Pendarvis
  Its:  

Secretary, Global General Counsel and Senior Vice

President – Organizational Development


This excerpt taken from the RMD 10-Q filed Feb 8, 2008.

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

February 7, 2008

ResMed Inc.

 

 

 

/s/ KIERAN T. GALLAHUE

 

Kieran T. Gallahue

Chief Executive Officer

 

 

 

 

/s/ BRETT A. SANDERCOCK

 

Brett A. Sandercock

Chief Financial Officer

 

- 45 -

This excerpt taken from the RMD 8-K filed Feb 7, 2008.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: February 7, 2008    

RESMED INC.

(registrant)

    By:   /s/ Brett Sandercock
      Name:   Brett Sandercock
      Its:   Vice President Finance and Chief Financial Officer

 

3


This excerpt taken from the RMD 8-K filed Feb 6, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 6, 2008     RESMED INC.
      By:   /s/ David Pendarvis
      Name:   David Pendarvis
      Its:  

Secretary, Global General

Counsel and Senior Vice

President –Organizational

Development


This excerpt taken from the RMD 8-K filed Dec 14, 2007.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: December 14, 2007    

RESMED INC.

(registrant)

    By:   /s/ David Pendarvis
      Name:   David Pendarvis
      Its:  

Secretary, Global General Counsel and

Senior Vice President - Organizational Development

 

3

This excerpt taken from the RMD 8-K filed Dec 14, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 14, 2007     RESMED INC.
      By:  

/s/ David Pendarvis

      Name:   David Pendarvis
      Its:   Secretary, Global General Counsel and Senior Vice President –Organizational Development


This excerpt taken from the RMD 10-Q filed Nov 9, 2007.

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

November 6, 2007

ResMed Inc.

 

 

 

/s/ PETER C. FARRELL

 

 

Peter C. Farrell

Chairman and Chief Executive Officer

 

 

 

 

/s/ BRETT A. SANDERCOCK

 

 

Brett A. Sandercock

Chief Financial Officer

 

- 42 -

This excerpt taken from the RMD 8-K filed Nov 1, 2007.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: November 1, 2007    

RESMED INC.

(registrant)

      By:   /s/ Brett Sandercock
      Name:   Brett Sandercock
      Its:   Vice President Finance and Chief Financial Officer

 

3


This excerpt taken from the RMD 8-K filed Aug 31, 2007.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: August 31, 2007

  RESMED INC.
  (registrant)
  By:  

/s/ David Pendarvis

  Name:   David Pendarvis
  Its:   Secretary, Global General Counsel and
    Senior Vice President - Organizational Development

 

3

This excerpt taken from the RMD 8-K filed Aug 7, 2007.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: August 7, 2007   RESMED INC.
  (registrant)
  By:  

/s/ Brett Sandercock

  Name:   Brett Sandercock
  Its:   Vice President Finance and Chief Financial Officer

 

3


This excerpt taken from the RMD 8-K filed Aug 3, 2007.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: August 3, 2007     RESMED INC.
      (registrant)
      By:   /s/ David Pendarvis
      Name:   David Pendarvis
      Its:   Secretary, Global General Counsel and
        Senior Vice President - Organizational Development

 

3

This excerpt taken from the RMD 8-K filed Jul 13, 2007.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: July 13, 2007   RESMED INC.
  (registrant)
  By:  

/s/ David Pendarvis

  Name:   David Pendarvis
  Its:   Secretary, Global General Counsel and
    Senior Vice President of Organizational Development

 

-3-


This excerpt taken from the RMD 8-K filed Jun 6, 2007.

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: June 6, 2007    

RESMED INC.

(registrant)

    By:   /s/ David Pendarvis
    Name:   David Pendarvis
    Its:  

Secretary, Global General Counsel and

Senior Vice President of Organizational

Development

 

-3-

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki